MDPI and ACS Style
Ferraz Barbosa, B.; Aquino de Moraes, F.C.; Bordignon Barbosa, C.; Palavicini Santos, P.T.K.; Pereira da Silva, I.; Araujo Alves da Silva, B.; Cristine Marques Barros, J.; RodrÃguez Burbano, R.M.; Pereira Carneiro dos Santos, N.; Rodrigues Fernandes, M.
Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis. J. Pers. Med. 2023, 13, 1460.
https://doi.org/10.3390/jpm13101460
AMA Style
Ferraz Barbosa B, Aquino de Moraes FC, Bordignon Barbosa C, Palavicini Santos PTK, Pereira da Silva I, Araujo Alves da Silva B, Cristine Marques Barros J, RodrÃguez Burbano RM, Pereira Carneiro dos Santos N, Rodrigues Fernandes M.
Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 2023; 13(10):1460.
https://doi.org/10.3390/jpm13101460
Chicago/Turabian Style
Ferraz Barbosa, Bárbara, Francisco Cezar Aquino de Moraes, Camila Bordignon Barbosa, PlÃnio Takashi Karubi Palavicini Santos, Izael Pereira da Silva, Bruno Araujo Alves da Silva, Jamile Cristine Marques Barros, Rommel Mario RodrÃguez Burbano, Ney Pereira Carneiro dos Santos, and Marianne Rodrigues Fernandes.
2023. "Efficacy and Safety of Setmelanotide, a Melanocortin-4 Receptor Agonist, for Obese Patients: A Systematic Review and Meta-Analysis" Journal of Personalized Medicine 13, no. 10: 1460.
https://doi.org/10.3390/jpm13101460
